An In Vitro Perspective on What Individual Antimicrobials Add to Mycobacterium avium Complex Therapies

For Mycobacterium avium complex pulmonary disease (MAC-PD), current treatment regimens yield low cure rates. To obtain an evidence-based combination therapy, we assessed the in vitro activity of six drugs, namely, clarithromycin (CLR), rifampin (RIF), ethambutol (EMB), amikacin (AMK), clofazimine (C...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Antimicrob Agents Chemother
Main Authors: Sonawane, Vidhisha V., Ruth, Mike M., Pennings, Lian J., Svensson, Elin M., Wertheim, Heiman F. L., Hoefsloot, Wouter, van Ingen, Jakko
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2021
Teme:
Clinical Therapeutics
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8284439/
https://ncbi.nlm.nih.gov/pubmed/33972258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02730-20
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki